RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BARINOTTI A
Collezione ASL Città di Torino

Items : 17

Biological therapies in thrombocytopenia and primary antiphospholipid syndrome: where are we now? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2025 Mar 28. doi: 10.1080/14712598.2025.2484844.

2025
ASL Città di Torino

Radin M; Barinotti A; Galarza D; Cecchi I; Camerlo S; Vaccarino A; Roccatello D; Morotti A; Sciascia S;

The Interconnection Between Systemic Lupus Erythematosus and Diet: Unmet Needs, Available Evidence, and Guidance-A Patient-Driven, Multistep-Approach Study. in Nutrients / Nutrients. 2024 Nov 29;16(23):4132. doi: 10.3390/nu16234132.

2024
ASL Città di Torino

Sciascia S; Ferrara G; Roccatello L; Rubini E; Foddai SG; Radin M; Cecchi I; Rossi D; Barinotti A; Ricceri F; Gilcrease W; Baldovino S; Ferreira Poshar A; Conti A; Fenoglio R;

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.

2024
ASL Città di Torino

Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L; Cioffi M; Foddai SG; Barinotti A; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.

2023
ASL Città di Torino

Sciascia S; Rilat MLA; Fenoglio R; Foddai SG; Radin M; Cecchi I; Cinnirella G; Crosasso P; Guidetti MG; Barinotti A; Baldovino S; Menegatti E; Roccatello D;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.

2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.

2023
ASL Città di Torino

Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D; Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis

2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.

2022
ASL Città di Torino

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.

2022
ASL Città di Torino

Foddai SG; Cecchi I; Rubini E; Radin M; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Quality of life measures in Systemic Lupus Erythematosus: A systematic review. in Reumatismo / Reumatismo. 2022 Feb 7;73(4). doi: 10.4081/reumatismo.2021.1447.

2022
ASL Città di Torino

Radin M; El Hasbani G; Barinotti A; Roccatello D; Uthman I; Taher A; Sciascia S;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.

2022
ASL Città di Torino

Radin M; Arbrile M; Cecchi I; Di Nunzio P; Buccarano N; Di Gregorio F; Milone V; Osella S; Crosasso P; Favuzzi MD; Barinotti A; Baldovino S; Menegatti E; Rossi D; Sciascia S; Roccatello D;

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.

2021
ASL Città di Torino

Cecchi I; Radin M; Rubini E; Foddai SG; Barinotti A; Roccatello D; Sciascia S;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.

2021
ASL Città di Torino

Radin M; Foddai SG; Barinotti A; Cecchi I; Rubini E; Sciascia S; Roccatello D;

Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology. in Thrombosis research / Thromb Res. 2021 Jun;202:100-103. doi: 10.1016/j.thromres.2021.03.019. Epub 2021 Mar 22.

2021
ASL Città di Torino

Radin M; Foddai S; Cecchi I; Rubini E; Barinotti A; Mahler M; Seaman A; Ramirez C; Casas S; Roccatello D; Sciascia S;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.

2021
ASL Città di Torino

Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.

2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D;

Prognostic and Diagnostic Values of Novel Serum and Urine Biomarkers in Lupus Nephritis: A Systematic Review. in American journal of nephrology / Am J Nephrol. 2021;52(7):559-571. doi: 10.1159/000517852. Epub 2021 Aug 13.

2021
ASL Città di Torino

Radin M; Miraglia P; Barinotti A; Fenoglio R; Roccatello D; Sciascia S;